Orthofix International reported $137.23M in Debt for its fiscal quarter ending in September of 2024.





Debt Change Date
Accuray USD 170.24M 4.52M Sep/2024
AngioDynamics USD 6.3M 6.3M Feb/2025
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 71.05M 736K Jun/2026
Dexcom USD 1.24B 154.7M Sep/2026
EDAP TMS EUR 27.79M 20.24M Mar/2026
Globus Medical USD 111.19M 4.03M Jun/2026
Inogen USD 0 0 Jun/2022
Insulet USD 962.1M 13.7M Sep/2026
Integra LifeSciences USD 2.05B 9.43M Jun/2026
J&J USD 49.04B 5.95B Jun/2026
Medtronic USD 28.15B 192M Jun/2026
Mesa Laboratories USD 204.98M 7.27M Sep/2024
Orthofix International USD 137.23M 338K Sep/2024
Plus Therapeutics USD 3.98M 372K Dec/2023
STAAR Surgical USD 35.94M 1.35M Jun/2026
Stryker USD 14.18B 16M Sep/2026
Tandem Diabetes Care USD 603.39M 811K Sep/2026
Teleflex USD 2.87B 186.84M Jun/2026
Veracyte USD 40.11M 774K Jun/2026
Zimmer Biomet Holdings USD 7.5B 25.2M Sep/2026